Difference between revisions of "DZI20-199-Case-5"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 46: Line 46:
 
|subject=Z0FBQUFBQmYxUUNEZWQtQ1VoMVZJUDhXdTNrSldqQzhHdnRLNWJySVNhTUtBNExBWmV0LU1aV3JPMzdvSnV2d0JCYUxCUmNQRDk3N2F6c0ZMek1aOWpLZ2NjeWVPSXFRY2c9PQ
 
|subject=Z0FBQUFBQmYxUUNEZWQtQ1VoMVZJUDhXdTNrSldqQzhHdnRLNWJySVNhTUtBNExBWmV0LU1aV3JPMzdvSnV2d0JCYUxCUmNQRDk3N2F6c0ZMek1aOWpLZ2NjeWVPSXFRY2c9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Mjf79
 +
|authoredOn=December 12, 2020 05:38:38 PM
 
}}
 
}}

Latest revision as of 13:59, December 9, 2024

DZI20-199-Case-5
pancreas mass - middle segment resection

FX2: Distal margin (radial)

FX2A: Tumor
FX2 (distal margin): Margin negative for high-grade dysplasia and malignancy. FX2A (tumor): At least intermediate grade dysplasia, negative for carcinoma (permanent: IPMN with high-grade dysplasia, branch duct type)
December 31, 1969 7:00:00 PM